​

T2 Biosystems (TTOO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TTOO Stock Forecast

T2 Biosystems (TTOO) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 3471.43% increase from the last price of $0.14.

- $1 $2 $3 $4 $5 $6 High: $5 Avg: $5 Low: $5 Last Closed Price: $0.14

TTOO Stock Rating

T2 Biosystems stock's rating consensus is Hold, based on 10 Wall Street analysts. The breakdown includes 1 Strong Buy (10.00%), 2 Buy (20.00%), 6 Hold (60.00%), 1 Sell (10.00%), and 0 Strong Sell (0.00%).

Hold
Total 10 0 1 6 2 1 Strong Sell Sell Hold Buy Strong Buy

TTOO Price Target Upside V Benchmarks

TypeNameUpside
StockT2 Biosystems3471.43%
SectorHealthcare Stocks 23.68%
IndustryDiagnostics & Research Stocks22.21%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$5.00
Last Closing Price$0.14$0.14$0.14
Upside/Downside--3471.43%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24212--5
Oct, 24212--5
Sep, 24212--5
Aug, 24213--6
Jul, 242-3--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2024Kyle MiksonCanaccord Genuity$5.00$4.745.49%3471.43%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 30, 2024Canaccord GenuityHoldHoldhold

Financial Forecast

EPS Forecast

$-3K $-2K $-2K $-1K $-500 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.03K$-1.68K$-1.24K$-19.19-----
Avg Forecast$-1.99K$-1.62K$-1.24K$-18.57$-3.10$-1.19$-0.70$-0.46$-0.30
High Forecast$-1.99K$-1.62K$-1.24K$-18.57$-3.10$-1.19$-0.70$-0.46$-0.30
Low Forecast$-1.99K$-1.62K$-1.24K$-18.57$-3.10$-1.19$-0.70$-0.46$-0.30
Surprise %2.00%3.73%0.52%3.34%-----

Revenue Forecast

$5M $17M $29M $41M $53M $65M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$18.13M$28.06M$22.30M$7.19M-----
Avg Forecast$18.28M$27.52M$22.20M$7.90M$10.55M$23.13M$33.30M$45.70M$60.40M
High Forecast$18.28M$27.52M$22.20M$8.01M$10.55M$23.13M$33.30M$45.70M$60.40M
Low Forecast$18.28M$27.52M$22.20M$7.79M$10.55M$23.13M$33.30M$45.70M$60.40M
Surprise %-0.84%1.94%0.47%-8.95%-----

Net Income Forecast

$-6B $-4B $-3B $-2B $-1B $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.21M$-53.49M$-63.37M$-50.08M-----
Avg Forecast$-5.19B$-45.81M$-44.89M$-48.26M$-8.09M$-3.11M$-1.83M$-1.20M$-783.00K
High Forecast$-5.19B$-36.65M$-35.92M$-38.61M$-8.09M$-3.11M$-1.83M$-1.20M$-783.00K
Low Forecast$-5.19B$-54.98M$-53.87M$-57.91M$-8.09M$-3.11M$-1.83M$-1.20M$-783.00K
Surprise %-99.05%16.76%41.15%3.76%-----

TTOO Forecast FAQ

Is T2 Biosystems stock a buy?

T2 Biosystems stock has a consensus rating of Hold, based on 10 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 2 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that T2 Biosystems is a neutral investment for most analysts.

What is T2 Biosystems's price target?

T2 Biosystems's price target, set by 10 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 3471.43% change from the previous closing price of $0.14.

How does T2 Biosystems stock forecast compare to its benchmarks?

T2 Biosystems's stock forecast shows a 3471.43% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the diagnostics & research stocks industry (22.21%).

What is the breakdown of analyst ratings for T2 Biosystems over the past three months?

  • November 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is T2 Biosystems’s EPS forecast?

T2 Biosystems's average annual EPS forecast for its fiscal year ending in December 2024 is $-3.1, marking a -83.85% decrease from the reported $-19.19 in 2023. Estimates for the following years are $-1.19 in 2025, $-0.7 in 2026, $-0.46 in 2027, and $-0.3 in 2028.

What is T2 Biosystems’s revenue forecast?

T2 Biosystems's average annual revenue forecast for its fiscal year ending in December 2024 is $10.55M, reflecting a 46.69% increase from the reported $7.19M in 2023. The forecast for 2025 is $23.13M, followed by $33.3M for 2026, $45.7M for 2027, and $60.4M for 2028.

What is T2 Biosystems’s net income forecast?

T2 Biosystems's net income forecast for the fiscal year ending in December 2024 stands at $-8.091M, representing a -83.84% decrease from the reported $-50.077M in 2023. Projections indicate $-3.106M in 2025, $-1.827M in 2026, $-1.201M in 2027, and $-783K in 2028.